A Study of the Absorption, Metabolism, and Excretion of GBT440 in Healthy Male Subjects

Clinical Trial
Study Details
Enrollment
7
Interventions
Description

GBT440 capsules followed by single dose of \[C14\] GBT440 oral suspension

Name
GBT440
Type
Drug
Phase
Phase 1
Status
COMPLETED
Study ID #
NCT02497924
Study Type
Interventional
Summary

This study will provide information regarding the metabolic pathway of GBT440, the need for evaluation of potential drug-drug interactions, and the need for studies in special populations. The administration of radiolabeled drug is necessary to fully characterize the rates and routes of elimination of GBT440, providing further quantitative information on the disposition of GBT440. The results from this study will permit a comprehensive comparison between animal and human routes of elimination and metabolic profiles of GBT440.

Study Overview
Conditions
Contacts and Locations
Locations
Facility

Covance Early Clinical Services
Madison, Wisconsin 53704
United States

GeoPoint
43.07305, -89.40123